U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 793

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:61717400
GRCh38:
Chr11:61949928
BEST1Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
2.
GRCh37:
Chr11:61717508
GRCh38:
Chr11:61950036
BEST1Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
3.
GRCh37:
Chr11:61717563
GRCh38:
Chr11:61950091
BEST1Retinitis Pigmentosa, Recessive, Vitelliform macular dystrophy 2, Autosomal dominant vitreoretinochoroidopathy
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
4.
GRCh37:
Chr11:61717607
GRCh38:
Chr11:61950135
BEST1Vitelliform macular dystrophy 2, not provided, Retinitis Pigmentosa, Recessive,
Autosomal dominant vitreoretinochoroidopathy
Benign
(Jul 7, 2018)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr11:61717715
GRCh38:
Chr11:61950243
BEST1Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive,
not provided
Benign
(Jun 26, 2018)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr11:61717811
GRCh38:
Chr11:61950339
BEST1Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
7.
GRCh37:
Chr11:61717815
GRCh38:
Chr11:61950343
BEST1Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
8.
GRCh37:
Chr11:61717870
GRCh38:
Chr11:61950398
BEST1Retinitis pigmentosa, Vitelliform macular dystrophy 2, Autosomal dominant vitreoretinochoroidopathy
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr11:61717900
GRCh38:
Chr11:61950428
BEST1Autosomal recessive bestrophinopathyLikely pathogenic
(Jan 30, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr11:61717904
GRCh38:
Chr11:61950432
BEST1not providedUncertain significance
(Aug 28, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr11:61718036
GRCh38:
Chr11:61950564
BEST1not providedBenign
(Jun 26, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr11:61718173
GRCh38:
Chr11:61950701
BEST1not providedLikely benign
(Jul 9, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr11:61718228
GRCh38:
Chr11:61950756
BEST1not providedLikely benign
(Jul 14, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:61719026
GRCh38:
Chr11:61951554
BEST1not providedBenign
(Jul 9, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr11:61719070
GRCh38:
Chr11:61951598
BEST1not providedBenign
(Jul 10, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr11:61719279
GRCh38:
Chr11:61951807
BEST1M1Vnot providedPathogenic
(May 29, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr11:61719283
GRCh38:
Chr11:61951811
BEST1T2SRetinal dystrophy, not providedPathogenic/Likely pathogenic
(Oct 12, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr11:61719286
GRCh38:
Chr11:61951814
BEST1I3Nnot providedLikely pathogenic
(Jul 12, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr11:61719289
GRCh38:
Chr11:61951817
BEST1T4Inot providedPathogenic
(Aug 12, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr11:61719291
GRCh38:
Chr11:61951819
BEST1Y5Nnot providedUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr11:61719294
GRCh38:
Chr11:61951822
BEST1T6Anot provided, Retinal dystrophyPathogenic/Likely pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr11:61719294
GRCh38:
Chr11:61951822
BEST1T6Pnot provided, Vitelliform macular dystrophy 2Pathogenic
(Aug 1, 2007)
no assertion criteria provided
23.
GRCh37:
Chr11:61719295
GRCh38:
Chr11:61951823
BEST1T6KVitelliform macular dystrophy 2Likely pathogenic
(Mar 29, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr11:61719295
GRCh38:
Chr11:61951823
BEST1T6Rnot providedPathogenic/Likely pathogenic
(Nov 10, 2023)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr11:61719298
GRCh38:
Chr11:61951826
BEST1S7Nnot providedUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr11:61719303
GRCh38:
Chr11:61951831
BEST1V9Lnot providedPathogenic
(Jul 19, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr11:61719303
GRCh38:
Chr11:61951831
BEST1V9MVitelliform macular dystrophy 2Pathogenic
(Sep 1, 1998)
no assertion criteria provided
28.
GRCh37:
Chr11:61719304
GRCh38:
Chr11:61951832
BEST1V9GVitelliform macular dystrophy 2Likely pathogenic
(Sep 11, 2017)
criteria provided, single submitter
29.
GRCh37:
Chr11:61719304
GRCh38:
Chr11:61951832
BEST1V9Anot providednot providedno assertion provided
30.
GRCh37:
Chr11:61719306
GRCh38:
Chr11:61951834
BEST1A10TRetinal dystrophy, not providedPathogenic
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr11:61719307
GRCh38:
Chr11:61951835
BEST1A10Vnot providedPathogenic
(Oct 13, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr11:61719310
GRCh38:
Chr11:61951838
BEST1N11Snot providedLikely pathogenic
(Aug 8, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr11:61719310
GRCh38:
Chr11:61951838
BEST1N11Inot providednot providedno assertion provided
34.
GRCh37:
Chr11:61719311
GRCh38:
Chr11:61951839
BEST1N11Knot providedConflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr11:61719311
GRCh38:
Chr11:61951839
BEST1not providedLikely benign
(Oct 5, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr11:61719313
GRCh38:
Chr11:61951841
BEST1A12Vnot providedUncertain significance
(Sep 17, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr11:61719313
GRCh38:
Chr11:61951841
BEST1A12GVitelliform macular dystrophy 2, Retinal dystrophyUncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:61719315
GRCh38:
Chr11:61951843
BEST1R13Gnot provided, Isolated macular dystrophyPathogenic/Likely pathogenic
(Jan 9, 2020)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr11:61719315
GRCh38:
Chr11:61951843
BEST1R13CVitelliform macular dystrophy 2, Retinal dystrophy, not provided
Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr11:61719316
GRCh38:
Chr11:61951844
BEST1R13Pnot providedLikely pathogenic
(Jan 1, 2017)
criteria provided, single submitter
41.
GRCh37:
Chr11:61719316
GRCh38:
Chr11:61951844
BEST1R13HRetinal dystrophy, not providedPathogenic/Likely pathogenic
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr11:61719319
GRCh38:
Chr11:61951847
BEST1L14Snot providedUncertain significance
(Oct 8, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr11:61719322
GRCh38:
Chr11:61951850
BEST1G15Dnot providedPathogenic
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:61719325
GRCh38:
Chr11:61951853
BEST1S16Ynot providedPathogenic
(Feb 8, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr11:61719325
GRCh38:
Chr11:61951853
BEST1S16Fnot providedPathogenic
(Jul 6, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr11:61719326-61719328
GRCh38:
Chr11:61951854-61951856
BEST1F17delnot providedUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr11:61719327
GRCh38:
Chr11:61951855
BEST1F17Inot providedLikely pathogenic
(Jun 17, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr11:61719328
GRCh38:
Chr11:61951856
BEST1F17Ynot providedLikely pathogenic
(Dec 1, 2019)
criteria provided, single submitter
49.
GRCh37:
Chr11:61719328
GRCh38:
Chr11:61951856
BEST1F17Cnot providednot providedno assertion provided
50.
GRCh37:
Chr11:61719329
GRCh38:
Chr11:61951857
BEST1F17Lnot providedUncertain significance
(Jul 26, 2019)
criteria provided, single submitter
51.
GRCh37:
Chr11:61719333
GRCh38:
Chr11:61951861
BEST1R19Cnot providedConflicting interpretations of pathogenicity
(Mar 11, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr11:61719334
GRCh38:
Chr11:61951862
BEST1R19Hnot providedLikely pathogenic
(Oct 17, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr11:61719336
GRCh38:
Chr11:61951864
BEST1L20VVitelliform macular dystrophy 2Pathogenic
(Apr 1, 2018)
no assertion criteria provided
54.
GRCh37:
Chr11:61719338
GRCh38:
Chr11:61951866
BEST1not providedLikely benign
(Mar 9, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr11:61719339
GRCh38:
Chr11:61951867
BEST1L21Vnot providedLikely pathogenic
(Sep 6, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr11:61719340
GRCh38:
Chr11:61951868
BEST1L21Rnot providedPathogenic
(Aug 30, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr11:61719340
GRCh38:
Chr11:61951868
BEST1L21Qnot providedLikely pathogenic
(Sep 7, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr11:61719344
GRCh38:
Chr11:61951872
BEST1not providedLikely benign
(Jun 12, 2020)
criteria provided, single submitter
59.
GRCh37:
Chr11:61719347
GRCh38:
Chr11:61951875
BEST1not providedLikely benign
(Apr 1, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr11:61719348
GRCh38:
Chr11:61951876
BEST1W24Rnot providedLikely pathogenic
(Apr 21, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr11:61719350
GRCh38:
Chr11:61951878
BEST1W24*not providedPathogenic
(Oct 5, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr11:61719350
GRCh38:
Chr11:61951878
BEST1W24Cnot providednot providedno assertion provided
63.
GRCh37:
Chr11:61719351
GRCh38:
Chr11:61951879
BEST1R25Wnot provided, Vitelliform macular dystrophy 2Pathogenic/Likely pathogenic
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr11:61719352
GRCh38:
Chr11:61951880
BEST1R25Qnot provided, Autosomal recessive bestrophinopathyPathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr11:61719354
GRCh38:
Chr11:61951882
BEST1G26Snot providedLikely pathogenic
(Sep 9, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr11:61719355
GRCh38:
Chr11:61951883
BEST1G26DRetinal dystrophyUncertain significance
(Jan 27, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr11:61719356
GRCh38:
Chr11:61951884
BEST1not providedLikely benign
(Mar 18, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr11:61719357
GRCh38:
Chr11:61951885
BEST1S27Gnot providedLikely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr11:61719358
GRCh38:
Chr11:61951886
BEST1S27Nnot providedLikely pathogenic
(Aug 31, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr11:61719359
GRCh38:
Chr11:61951887
BEST1S27Rnot providednot providedno assertion provided
71.
GRCh37:
Chr11:61719362
GRCh38:
Chr11:61951890
BEST1not providedLikely benign
(Dec 15, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr11:61719363
GRCh38:
Chr11:61951891
BEST1Y29Hnot providedPathogenic
(Nov 1, 2017)
criteria provided, single submitter
73.
GRCh37:
Chr11:61719364
GRCh38:
Chr11:61951892
BEST1Y29CVitelliform macular dystrophy 2, not providedLikely pathogenic
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:61719365
GRCh38:
Chr11:61951893
BEST1not providednot providedno assertion provided
75.
GRCh37:
Chr11:61719365
GRCh38:
Chr11:61951893
BEST1Y29*not providedPathogenic
(Sep 6, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr11:61719367
GRCh38:
Chr11:61951895
BEST1K30RRetinal dystrophy, not provided, Vitelliform macular dystrophy 2
Conflicting interpretations of pathogenicity
(Sep 29, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr11:61719371
GRCh38:
Chr11:61951899
BEST1not providedLikely benign
(Aug 31, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr11:61719373
GRCh38:
Chr11:61951901
BEST1L32Pnot providedLikely pathogenic
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr11:61719375
GRCh38:
Chr11:61951903
BEST1Y33DRetinal dystrophyUncertain significance
(Jul 11, 2019)
criteria provided, single submitter
80.
GRCh37:
Chr11:61719375
GRCh38:
Chr11:61951903
BEST1Y33HRetinal dystrophy, not providedConflicting interpretations of pathogenicity
(May 27, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr11:61719377
GRCh38:
Chr11:61951905
BEST1not providedLikely benign
(May 19, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr11:61719380
GRCh38:
Chr11:61951908
BEST1not providedPathogenic
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr11:61719381
GRCh38:
Chr11:61951909
BEST1E35KAutosomal recessive bestrophinopathy, BEST1-related condition, not provided
Pathogenic/Likely pathogenic
(Jul 17, 2023)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr11:61719383
GRCh38:
Chr11:61951911
BEST1E35DAutosomal recessive bestrophinopathyUncertain significancecriteria provided, single submitter
85.
GRCh37:
Chr11:61719387-61719388
GRCh38:
Chr11:61951915-61951916
BEST1L37Pnot providedUncertain significance
(Aug 15, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr11:61719387
GRCh38:
Chr11:61951915
BEST1not specified, not provided, Retinitis pigmentosa,
Autosomal dominant vitreoretinochoroidopathy, Retinitis pigmentosa 50, Autosomal recessive bestrophinopathy,
Vitelliform macular dystrophy 2
Benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr11:61719391
GRCh38:
Chr11:61951919
BEST1I38Snot providedUncertain significance
(Mar 15, 2017)
criteria provided, single submitter
88.
GRCh37:
Chr11:61719395
GRCh38:
Chr11:61951923
BEST1not providedLikely benign
(Jun 20, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr11:61719396-61719397
GRCh38:
Chr11:61951924-61951925
BEST1L41fsnot providedPathogenic
(Aug 3, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr11:61719400
GRCh38:
Chr11:61951928
BEST1L41Pnot providedPathogenic
(Jul 30, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr11:61719411
GRCh38:
Chr11:61951939
BEST1I45Vnot providedUncertain significance
(Jul 17, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr11:61719413
GRCh38:
Chr11:61951941
BEST1not providedLikely benign
(Mar 10, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr11:61719415
GRCh38:
Chr11:61951943
BEST1I46Tnot providedUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr11:61719417
GRCh38:
Chr11:61951945
BEST1R47CRetinitis pigmentosa, Autosomal dominant vitreoretinochoroidopathy, not provided,
Vitelliform macular dystrophy 2
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr11:61719418
GRCh38:
Chr11:61951946
BEST1R47Lnot providedLikely pathogenic
(Oct 13, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:61719418
GRCh38:
Chr11:61951946
BEST1R47Hnot provided, Vitelliform macular dystrophy 2Pathogenic/Likely pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr11:61719419
GRCh38:
Chr11:61951947
BEST1not providedLikely benign
(Jan 14, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr11:61719428
GRCh38:
Chr11:61951956
BEST1not providedLikely benign
(Dec 28, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr11:61719430
GRCh38:
Chr11:61951958
BEST1R51Knot providedUncertain significance
(Jan 6, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr11:61719436
GRCh38:
Chr11:61951964
BEST1Retinitis pigmentosa, Vitelliform macular dystrophy 2, not provided,
Autosomal dominant vitreoretinochoroidopathy
Conflicting interpretations of pathogenicity
(Sep 19, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination